Developing a national medicines information strategy in Finland: A stakeholders` perspective on the strengths‚ challenges and opportunities in medicines information
Hämeen-Anttila, K; Luhtanen, S; Airaksinen, M; Pohjanoksa-Mäntylä, M (2013)
Tätä artikkelia/julkaisua ei ole tallennettu Julkariin. Julkaisun tiedoissa voi kuitenkin olla linkki toisaalle tallennettuun artikkeliin/julkaisuun.
Hämeen-Anttila, K
Luhtanen, S
Airaksinen, M
Pohjanoksa-Mäntylä, M
2013
Health Policy
Tiivistelmä
Purpose and setting: The Finnish Medicines Agency was mandated to develop a national
medicines information strategy.The objectives of this study were to assess stakeholders’
views on strengths,challenges and opportunities in medicines information for the basis of
the strategy.
Methods: Interviews among stakeholder representatives (n = 28) from patient organizations, universities, pharmacies,and professional associations in medicine, pharmacy and nursing were conductedin2011. Interviewmemos were thematically content-analysed.The draft strategy was finalized through two public hearings and a public consultation.
Results: Stakeholders highlighted the need to increase cooperation and coordination in
medicines information.The existence of numerous quality-and evidence-based medicines
information sources was identified as astrength; although the stakeholders were con-
cerned about the fragmented and unequal access to them.The strengthening of the role of
health care professionals in communicating about medicines was seen as an opportunity,
but its realization requires improvements in basic and continuing education.Furthermore,
the stakeholders emphasized the importance of uniform medicines information regardless
of source.
Conclusions: Stakeholders identified multiple strengths,challenges and opportunities in
medicines information that were fundamental to developing the national medicines infor-
mation strategy.An inventory of stakeholder perspectives can be recommended as a tool
to support decision-making in pharmaceutical policy.
medicines information strategy.The objectives of this study were to assess stakeholders’
views on strengths,challenges and opportunities in medicines information for the basis of
the strategy.
Methods: Interviews among stakeholder representatives (n = 28) from patient organizations, universities, pharmacies,and professional associations in medicine, pharmacy and nursing were conductedin2011. Interviewmemos were thematically content-analysed.The draft strategy was finalized through two public hearings and a public consultation.
Results: Stakeholders highlighted the need to increase cooperation and coordination in
medicines information.The existence of numerous quality-and evidence-based medicines
information sources was identified as astrength; although the stakeholders were con-
cerned about the fragmented and unequal access to them.The strengthening of the role of
health care professionals in communicating about medicines was seen as an opportunity,
but its realization requires improvements in basic and continuing education.Furthermore,
the stakeholders emphasized the importance of uniform medicines information regardless
of source.
Conclusions: Stakeholders identified multiple strengths,challenges and opportunities in
medicines information that were fundamental to developing the national medicines infor-
mation strategy.An inventory of stakeholder perspectives can be recommended as a tool
to support decision-making in pharmaceutical policy.
Kokoelmat
- Artikkelit [186]